Abbott, Teva Reach Deal That Delays Generic TriCor

Abbott Laboratories said Monday that it has reached a deal with Teva Pharmaceuticals that postpones the sale of a generic version of the blockbuster cholesterol drug TriCor until March 28, 2011, at the earliest.

The details can be read here.